Lobe Sciences Ltd.
LOBE
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.18% | -62.78% | -40.65% | 7.49% | 50.89% |
| Total Depreciation and Amortization | -100.00% | -71.64% | -20.42% | 91.41% | 267.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.88% |
| Total Other Non-Cash Items | 1,366.49% | 586.03% | 564.51% | 78.96% | -92.94% |
| Change in Net Operating Assets | -20.21% | -58.26% | -39.51% | -13.05% | 7.05% |
| Cash from Operations | 8.04% | -290.80% | 22.56% | 73.53% | 36.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 2,484.64% | 1,010.00% | 67.21% | 67.21% | 0.24% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,120.54% | -- | -- | -- | -99.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 2,391.42% | 1,339.19% | 53.31% | -41.41% | -78.56% |
| Foreign Exchange rate Adjustments | -475.00% | -151.43% | 944.44% | -380.00% | -161.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,140.52% | 111.33% | 95.06% | 112.24% | -906.86% |